Tumor blood volume determination by using susceptibility-corrected ΔR2* multiecho MR 1

Radiology

Volumn 255, Issue 3, 2010, Pages 781-789

  Persigehl, Thorsten ^a   Wall, Alexander ^a   Kellert, Julia ^a   Ring, Janine ^a   Remmele, Stefanie ^b   Heindel, Walter ^a   Dahnke, Hannes ^b   Bremer, Christoph ^a,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOSE RESPONSE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINEAR SYSTEM; MEASUREMENT; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR BLOOD FLOW; TUMOR VOLUME; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; FERROSOFERRIC OXIDE; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHANTOMS, IMAGING; TUMOR CELLS, CULTURED;

EID: 77952704485     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10090832     Document Type: Article

References (25)

1. Duda DG, Jain RK, Willett CG. Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J Clin Oncol 2007;25(26):4033-4042.
2. Jain RK. Antiangiogenic therapy for cancer: current and emerging concepts [Williston Park]. Oncology (Williston Park) 2005;19(4 suppl 3):7-16.
3. Mousa SA, Mousa AS. Angiogenesis inhibitors: current & future directions. Curr Pharm Des 2004;10(1):1-9. (Pubitemid 38072739)
4. Winer E, Gralow J, Diller L, et al. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 2009;27(5):812-826.
5. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307(5706):58-62.
6. Daldrup HE, Shames DM, Husseini W, Wendland MF, Okuhata Y, Brasch RC. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med 1998;40(4): 537-543. (Pubitemid 28440021)
7. Galbraith SM, Lodge MA, Taylor NJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15(2):132-142.
8. Kiessling F, Jugold M, Woenne EC, Brix G. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Eur Radiol 2007;17(8):2136-2148. (Pubitemid 47097471)
9. Bremer C, Mustafa M, Bogdanov A Jr, Ntziachristos V, Petrovsky A, Weissleder R. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology 2003;226(1):214-220. (Pubitemid 36163932)
10. Wu EX, Tang H, Jensen JH. Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models. NMR Biomed 2004;17(7):478-483. (Pubitemid 39549425)
11. Persigehl T, Matuszewski L, Kessler T, et al. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging. Invest Radiol 2007;42(12):791-796.
12. Reichardt W, Hu-Lowe D, Torres D, Weissleder R, Bogdanov A Jr. Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model. Neoplasia 2005; 7(9):847-853.
13. Persigehl T, Bieker R, Matuszewski L, et al. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology 2007;244(2):449-456.
14. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40(6):793-799. (Pubitemid 28543828)
15. Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002;223(2):432-438. (Pubitemid 34454322)
16. Taupitz M, Schmitz S, Hamm B. Super-paramagnetic iron oxide particles: current state and future development [in German]. Rofo 2003;175(6):752-765. (Pubitemid 36806756)
17. Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002;55(5):294-299. (Pubitemid 35193254)
18. Zhu H, Melder RJ, Baxter LT, Jain RK. Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. Cancer Res 1996;56(16):3771-3781. (Pubitemid 26272028)
19. Reimer P, Bremer C, Allkemper T, et al. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study. Radiology 2004;231(2):474-481. (Pubitemid 38552907)
20. Van Oosterhout MF, Willigers HM, Reneman RS, Prinzen FW. Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique. Am J Physiol 1995;269(2 pt 2): H725-H733.
21. Hyodo F, Chandramouli GV, Matsumoto S, et al. Estimation of tumor microvessel density by MRI using a blood pool contrast agent. Int J Oncol 2009;35(4):797-804.
22. Matuszewski L, Persigehl T, Wall A, et al. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience. Radiology 2007;242(1): 217-224.
23. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14(2): 249-265.
24. Troprès I, Grimault S, Vaeth A, et al. Vessel size imaging. Magn Reson Med 2001;45(3): 397-408.
25. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 1997;7(2): 266-279. (Pubitemid 28356957)